These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 20362335

  • 1. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Galván AB, Mallo M, Arenillas L, Salido M, Espinet B, Pedro C, Florensa L, Serrano S, Solé F.
    Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
    [Abstract] [Full Text] [Related]

  • 2. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M.
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [Abstract] [Full Text] [Related]

  • 3. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
    Xu W, Li JY, Liu Q, Zhu Y, Pan JL, Qiu HR, Xue YQ.
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
    [Abstract] [Full Text] [Related]

  • 4. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
    Sun Y, Cook JR.
    Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
    [Abstract] [Full Text] [Related]

  • 5. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D, Hildebrandt B, Beier M, Müller N, Germing U, Royer-Pokora B.
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [Abstract] [Full Text] [Related]

  • 6. Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20.
    Mackinnon RN, Campbell LJ.
    Cytogenet Genome Res; 2007 Feb; 119(3-4):211-20. PubMed ID: 18253031
    [Abstract] [Full Text] [Related]

  • 7. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [Abstract] [Full Text] [Related]

  • 8. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, Haferlach C.
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [Abstract] [Full Text] [Related]

  • 9. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [Abstract] [Full Text] [Related]

  • 10. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A, Ades L, Baran-Marzack F, Mozziconacci MJ, Penther D, Dobbelstein S, Stamatoullas A, Récher C, Prebet T, Moulessehoul S, Fenaux P, Eclache V.
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [Abstract] [Full Text] [Related]

  • 11. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Löffler H, Hiddemann W.
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, Morice P, Abgrall JF, Berthou C, De Braekeleer M.
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [Abstract] [Full Text] [Related]

  • 13. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V, Castagné C, Mühlematter D, Parlier V, Gmür J, Hess U, Kovacsovics T, Meyer-Monard S, Tichelli A, Tobler A, Jacky E, Schanz U, Bargetzi M, Hagemeijer A, de Witte T, van Melle G, Jotterand M.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):29-41. PubMed ID: 15193439
    [Abstract] [Full Text] [Related]

  • 14. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S, Rödjer S, Swolin B.
    Cancer Genet Cytogenet; 2004 Nov 01; 155(1):74-8. PubMed ID: 15527906
    [Abstract] [Full Text] [Related]

  • 15. Submicroscopic deletions in 5q- associated malignancies.
    Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G, Aventin A, Marynen P, Ciolli S, Nozzoli C, Martelli MF, Mecucci C.
    Haematologica; 2004 Mar 01; 89(3):281-5. PubMed ID: 15020265
    [Abstract] [Full Text] [Related]

  • 16. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA, Ferguson W, Mark HF.
    Cancer Genet Cytogenet; 1999 Dec 01; 115(2):106-13. PubMed ID: 10598142
    [Abstract] [Full Text] [Related]

  • 17. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z, Sahin FI, Kizilkilic E, Karakus S, Boga C, Ozdogu H.
    Clin Exp Med; 2005 Jul 01; 5(2):55-9. PubMed ID: 16096854
    [Abstract] [Full Text] [Related]

  • 18. Detection of monosomy 7 by fluorescence in situ hybridization in acute nonlymphocytic leukemia and myelodysplastic syndrome.
    Nakagawa H.
    Jpn J Hum Genet; 1993 Sep 01; 38(3):257-66. PubMed ID: 8260718
    [Abstract] [Full Text] [Related]

  • 19. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN, Kannourakis G, Wall M, Campbell LJ.
    Cancer Genet; 2011 Apr 01; 204(4):187-94. PubMed ID: 21536236
    [Abstract] [Full Text] [Related]

  • 20. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T, Yasuyama M, Kawauchi K.
    Am J Hematol; 2005 Jun 01; 79(2):136-41. PubMed ID: 15929101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.